SKI Market

Indian Indices

Sensex

81,537.70 -769.67
( -0.94%)

Global Indices

Nasdaq

49,128.98 -276.04
(-0.56%)

Dow Jones

6,938.97 4.62
(0.07%)

Hang Seng

53,831.56 142.67
(0.27%)

Nikkei 225

10,138.52 -11.53
(-0.11%)

Forex

USD-INR

91.58 0.09
(0.10%)

EUR-INR

107.27 0.14
(0.13%)

GBP-INR

123.20 0.33
(0.27%)

JPY-INR

0.58 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kilitch Drugs (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524500

INE729D01010

180.7312064

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KILITCH

17.28

548.98

EPS(TTM)

Face Value()

Div & Yield %

18.17

Back

Havells India consolidated net profit rises 8.08% in the December 2025 quarter

Jan 19,2026

Net profit of Havells India rose 8.08% to Rs 300.78 crore in the quarter ended December 2025 as against Rs 278.30 crore during the previous quarter ended December 2024. Sales rose 14.30% to Rs 5587.89 crore in the quarter ended December 2025 as against Rs 4888.98 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	5587.89	4888.98	14
OPM %	9.24	8.72	-
PBDT	561.27	481.44	17
PBT	452.65	377.34	20
NP	300.78	278.30	8

81,537.70 -769.67 ( -0.94%)

49,128.98 -276.04 (-0.56%)

6,938.97 4.62 (0.07%)

53,831.56 142.67 (0.27%)

10,138.52 -11.53 (-0.11%)

91.58 0.09 (0.10%)

107.27 0.14 (0.13%)

123.20 0.33 (0.27%)

0.58 0.00 (-0.17%)